Botulism in the United States: A Clinical and Epidemiologic Review
Publication: Annals of Internal Medicine
Volume 129, Number 3
Abstract
Botulism is caused by a neurotoxin produced from the anaerobic, spore-forming bacterium Clostridium botulinum. Botulism in humans is usually caused by toxin types A, B, and E. Since 1973, a median of 24 cases of foodborne botulism, 3 cases of wound botulism, and 71 cases of infant botulism have been reported annually to the Centers for Disease Control and Prevention (CDC). New vehicles for transmission have emerged in recent decades, and wound botulism associated with black tar heroin has increased dramatically since 1994. Recently, the potential terrorist use of botulinum toxin has become an important concern.
Botulism is characterized by symmetric, descending, flaccid paralysis of motor and autonomic nerves, usually beginning with the cranial nerves.Blurred vision, dysphagia, and dysarthria are common initial complaints. The diagnosis of botulism is based on compatible clinical findings; history of exposure to suspect foods; and supportive ancillary testing to rule out other causes of neurologic dysfunction that mimic botulism, such as stroke, the Guillain-Barre syndrome, and myasthenia gravis. Laboratory confirmation of suspected cases is performed at the CDC and some state laboratories. Treatment includes supportive care and trivalent equine antitoxin, which reduces mortality if administered early. The CDC releases botulism antitoxin through an emergency distribution system. Although rare, botulism outbreaks are a public health emergency that require rapid recognition to prevent additional cases and to effectively treat patients. Because clinicians are the first to treat patients in any type of botulism outbreak, they must know how to recognize, diagnose, and treat this rare but potentially lethal disease.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Smith LD, Sugiyama H. Botulism: The Organism, Its Toxins, The Disease. 2d ed. Springfield, IL: Charles C. Thomas; 1988.
2.
Meyer KF. The rise and fall of botulism. Calif Med. 1973; 118:63-4.
3.
van Ermengem E. Classics in infectious disease. A new anaerobic bacillus and its relation to botulism. E. van Ermengem. Originally published as “Uber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus,” in Zeitschrift fur Hygiene und Infektionskrankheiten, 26:1-56. 1897. Rev Infect Dis. 1979; 1:701-19.
4.
Cato EP, George WL, Finegold SM. Genus Clostridium. In: Sneath PH, Mair NS, Sharpe ME, Hold JG, eds. Bergey's Manual of Systematic Bacteriology. v 2. Baltimore: Williams & Wilkins; 1986:1141.
5.
Hall JD, McCroskey LM, Pincomb BJ, Hatheway CL. Isolation of an organism resembling Clostridium baratii which produces type F botulinal toxin from an infant with botulism. J Clin Microbiol. 1985; 21:654-5.
6.
McCroskey LM, Hatheway CL, Woodruff BA, Greenberg JA, Jurgenson P. Type F botulism due to neurotoxigenic Clostridium baratii from an unknown source in an adult. J Clin Microbiol. 1991; 29:2618-20.
7.
Aureli P, Fenicla L, Pasolini B, Glanfranceschi M, McCroskey LM, Hatheway CL. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis. 1986; 154:207-11.
8.
Lund BM. Foodborne disease due to Bacillus and Clostridium species. Lancet. 1990; 336:982-6.
9.
Bowmer EJ. Preparation and assay of the international standards for Clostridium botulinum types A, B, C, D and E antitoxins. Bull World Health Organ. 1963; 29:701-9.
10.
Hatheway CL. Toxigenic clostridia. Clin Microbiol Rev. 1990; 3:66-98.
11.
Halpern JL, Neale EA. Neurospecific binding, internalization, and retrograde axonal transport. In: Montecucco C, ed. Clostridial Neurotoxins. Current Topics in Microbiology and Immunology. v 195. New York: Springer; 1995:221.
12.
Schiavo G, Rossetto O, Tonello F, Montecucco C. Intracellular targets and metalloprotease activity of tetanus and botulism neurotoxins. Curr Top Microbiol Immunol. 1995; 195:257-74.
13.
Eitzen LT, Caudle MA. Medical Management of Biological Casualties. Fort Detrick, MD: U.S. Army Medical Research Institute of Infectious Diseases; 1993. Publication no. 20170-5011.
14.
Thompson DE, Brehm JK, Oultram JD, Swinfield TJ, Shone CC, Atkinson T, et al. The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene. Eur J Biochem. 1990; 189:73-81.
15.
Binz T, Kurazono H, Willie M, Frevert J, Wernars K, Niemann H. The complete sequence of botulism neurotoxin type A and comparison with other clostridial neurotoxins. J Biol Chem. 1990; 265:9153-8.
16.
Whelan SM, Elmore MJ, Bodsworth NJ, Brehm JK, Atkinson T, Minton NP. Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence. Appl Environ Microbiol. 1992; 58:2345-54.
17.
Hauser D, Eklund MW, Kurazono H, Binz T, Niemann H, Gill DM, et al. Nucleotide sequence of Clostridium botulinum C1 neurotoxin. Nucleic Acids Res. 1990; 18:4924.
18.
Binz T, Kurazono H, Popoff MR, Eklund MW, Sakaguchi G, Kozaki S, et al. Nucleotide sequence of the genes encoding Clostridium botulinum neurotoxin type D. Nucleic Acids Res. 1990; 18:5556.
19.
Whelan SM, Elmore MJ, Bodsworth NJ, Atkinson T, Minton NP. The complete amino acid sequence of Clostridium botulinum type-E neurotoxin, derived by nucleotide-sequence analysis of the encoding gene. Eur J Biochem. 1992; 204:657-67.
20.
Elmore MJ, Hutson RA, Collins MD, Bodsworth NJ, Whelan SM, Minton W. Nucleotide sequence of the gene encoding for proteolytic (Group 1) Clostridium botulinum type F neurotoxin: genealogical comparison with other clostridial neurotoxins. Systematic and Applied Microbiology. 1995; 18:23-31.
21.
East AK, Richardson PT, Allaway D, Collins M, Roberts TA, Thompson DE. Sequence of the gene encoding type F neurotoxin of Clostridium botulinum. FEMS Microbiol Lett. 1992; 75:225-30.
22.
Campbell K, Collins MD, East AK. Nucleotide sequence of the gene coding for Clostridium botulinum (Clostridium argentinense) type G neurotoxin: genealogical comparison with other clostridial neurotoxins. Biochem Biophys Acta. 1993; 1216:487-91.
23.
McNally RE, Morrison MB, Berndt JE, Fisher JE, Bo-Berry JI, Packett VE, et al. Effectiveness of Medical Defense Interventions against Predicted Battlefield Levels of Botulinum Toxin A. Joppa, MD: Science Applications International; 1994.
24.
Hughes JM, Hatheway CL, Ostroff SM. Botulism. In: Scheld WM, Whitley RJ, Durack DT, eds. Infections of the Central Nervous System. 2d ed. Philadelphia: Lippincott-Raven; 1997:615.
25.
Horwitz MA, Hughes JM, Merson MH, Gangarosa EJ. Food-borne botulism in the United States, 1970-1975. J Infect Dis. 1977; 136:153-9.
26.
Wainwright RB, Heyward WL, Middaugh JP, Hatheway CL, Harpster AP, Bender TR. Food-borne botulism in Alaska, 1947-1985: epidemiology and clinical findings. J Infect Dis. 1988; 157:1158-62.
27.
Eisenberg MS, Bender TR. Botulism in Alaska, 1947 through 1974. Early detection of cases and investigation of outbreaks as a means of reducing mortality. JAMA. 1976; 235:35-8.
28.
Seals JE, Snyder JB, Edell TA, Hatheway CL, Johnson CJ, Swanson RC, et al. Restaurant-associated type A botulism: transmission by potato salad. Am J Epidemiol. 1981; 113:436-44.
29.
Townes JM, Cieslak PR, Hatheway CL, Solomon HM, Holloway JT, Baker MP, et al. An outbreak of type A botulism associated with a commercial cheese sauce. Ann Intern Med. 1996; 125:558-63.
30.
MacDonald KL, Spengler RF, Hatheway CL, Hargrett NT, Cohen ML. Type A botulism from sauteed onions. Clinical and epidemiologic observations. JAMA. 1985; 253:1275-8.
31.
St. Louis ME, Peck SH, Bowering D, Morgan GB, Blatherwick J, Banerjee S, et al. Botulism from chopped garlic: delayed recognition of a major outbreak. Ann Intern Med. 1988; 108:363-8.
32.
MacDonald KL, Cohen ML, Blake PA. The changing epidemiology of adult botulism in the United States. Am J Epidemiol. 1986; 124:794-9.
33.
Botulism (foodborne)-by year, United States, 1975-1994. MMWR Morb Mortal Wkly Rep. 1995; 43:22.
34.
Wound botulism-California, 1995. MMWR Morb Mortal Wkly Rep. 1995; 44:889-92.
35.
Passaro DJ, Werner SB, McGee J, MacKenzie WR, Vugia DJ. Wound botulism associated with black tar heroin among injecting drug users. JAMA. 1998; 279:859-63.
36.
Bakheit AM, Ward CD, McLellan DL. Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases [Letter]. J Neurol Neurosurg Psych. 1997; 62:198.
37.
Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve. 1997; S6:146-68.
38.
Cole LA. The specter of biological weapons. Sci Am. 1996; 275:60-5.
39.
Ekeus R. Report of the Secretary General on the status of the implementation of the Special Commission's plan for the ongoing monitoring and verification of Iraq's compliance with relevant parts of Sector C of Security Council Resolution 687. New York: United Nations Special Commission (UNSCOM); 1991.
40.
Danzig R. Biological warfare: a nation at risk-a time to act. Strategic Forum. 1996; 58:1-4.
41.
Woodruff BA, Griffin PM, McCroskey LM, Smart JF, Wainwright RB, Bryant RG, et al. Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988. J Infect Dis. 1992; 166:1281-6.
42.
Hughes JM, Blumenthal JR, Merson MH, Lombard GL, Dowell VR Jr, Gangarosa EJ. Clinical features of types A and B food-borne botulism. Ann Intern Med. 1981; 95:442-5.
43.
Centers for Disease Control and Prevention. Botulism in the United States, 1899-1973: Handbook for Epidemiologists, Clinicians, and Laboratory Workers. Atlanta: Centers for Disease Control; 1978:3. Publication no. (CDC) 74-8279/G.
44.
Duchen LW. An electron microscopic study of the changes induced by botulism toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse. J Neurol Sci. 1971; 14:47-60.
45.
Tsujihata M, Kinoshita I, Mori M, Mori K, Shirabe S, Satoh A, et al. Ultrastructural study of the motor end-plate in botulism and Lambert-Eaton myasthenic syndrome. J Neurol Sci. 1987; 81:197-213.
46.
Merson MH, Dowell VR Jr. Epidemiologic, clinical and laboratory aspects of wound botulism. N Engl J Med. 1973; 289:1105-10.
47.
Hatheway CL Botulism: the present status of the disease. In: Montecucco C, ed. Clostridial Neurotoxins. Current Topics in Microbiology and Immunology. v 195. New York: Springer; 1995:55.
48.
Wilson R, Morris JG Jr, Snyder JD, Feldman RA. Clinical characteristics of infant botulism in the United States: a study of the non-California cases. Pediatr Infect Dis. 1982; 1:148-50.
49.
Arnon SS. Infant botulism. In: Feigen RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 4th ed. Philadelphia: WB Saunders; 1998:1570-7.
50.
Spika JS, Shaffer N, Hargrett-Bean N, Collin DS, MacDonald KL, Blake PA. Risk factors for infant botulism in the United States. Am J Dis Child. 1989; 143:828-32.
51.
Botulism-United States, 1978. MMWR Morb Mortal Wkly Rep. 1979; 28:73-5.
52.
Griffin PM, Hatheway CL, Rosenbaum RB, Sokolow R. Endogenous antibody production to botulism toxin in an adult with intestinal colonization botulism and underlying Crohn's disease. J Infect Dis. 1997; 175:633-7.
53.
McCroskey LM, Hatheway CL. Laboratory findings in four cases of adult botulism suggest colonization of the intestinal tract. J Clin Microbiol. 1988; 26:1052-4.
54.
Chia JK, Clark JB, Ryan CA, Pollack M. Botulism in an adult associated with food-borne intestinal infection with Clostridium botulinum. N Engl J Med. 1986; 315:239-41.
55.
St Louis ME. Botulism. In: Evans AS, Brachman PS, eds. Bacterial Infections of Humans: Epidemiology and Control. 2d ed. New York: Plenum Medical; 1991:115.
56.
Hatheway CL. Botulism. In: Balows A, Hausler WH, Lennette EH, eds. Laboratory Diagnosis of Infectious Diseases: Principles and Practice. v 1. New York: Springer-Verlag; 1988:111.
57.
Hatheway CL, Ferreira JL. Detection and identification of Clostridium botulinum neurotoxins. In: Singh BR, Tu AT, eds. Natural Toxins II: Proceedings of a Symposium. 209th American Chemical Society National Meeting, Anaheim, CA, 2-7 April 1995. New York: Plenum; 1996; 481-98.
58.
Szabo EA, Pemberton JM, Gibson AM, Eyles MJ, Desmarchelier PM. Polymerase chain reaction for detection of Clostridium botulinum types A, B, and E in food, soil and infant faeces. J Appl Bacteriol. 1994; 76:539-45.
59.
Dowell VR Jr, McCroskey LM, Hatheway CL, Lombard GL, Hughes JM, Merson MH. Coproexamination for botulinal toxin and Clostridium botulinum. A new procedure for laboratory diagnosis of botulism. JAMA. 1977; 238:1829-32.
60.
Hatheway CL, Snyder JD, Seals JE, Edell TA, Lewis GE Jr. Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E. J Infect Dis. 1984; 150:407-12.
61.
Black RE, Gunn RA. Hypersensitivity reactions associated with botulinal antitoxin. Am J Med. 1980; 69:567-70.
62.
Tacket CO, Shandera WX, Mann JM, Hargrett NT, Blake PA. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med. 1984; 76:794-98.
Information & Authors
Information
Published In
Annals of Internal Medicine
Volume 129 • Number 3 • 1 August 1998
Pages: 221 - 228
History
Published in issue: 1 August 1998
Published online: 15 August 2000
Keywords
Copyright
© 1998 American College of Physicians.
Authors
Metrics & Citations
Metrics
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
Download article citation data for:
Botulism in the United States: A Clinical and Epidemiologic Review. Ann Intern Med.1998;129:221-228. doi:10.7326/0003-4819-129-3-199808010-00011
Botulism in the United States: A Clinical and Epidemiologic Review. Ann Intern Med.1998;129:221-228. doi:10.7326/0003-4819-129-3-199808010-00011
View More
Get Access
Login Options:
Purchase
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
Create your Free Account
You will be redirected to acponline.org to create an account that will provide access to Annals.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.